Factors associated, symptoms, and treatments of guillain-barré syndrome: a narrative review

Authors

  • Emilia López-Peña Escuela Profesional de Enfermería, Facultad de Ciencias de la Salud, Universidad Peruana Unión, San Martín, Perú Author
  • Diana Camizán-Julca Escuela Profesional de Enfermería, Facultad de Ciencias de la Salud, Universidad Peruana Unión, San Martín, Perú Author
  • Jonathan Dávila-Pezo Escuela Profesional de Enfermería, Facultad de Ciencias de la Salud, Universidad Peruana Unión, San Martín, Perú Author
  • Sayra Morales-Ruiz Escuela Profesional de Enfermería, Facultad de Ciencias de la Salud, Universidad Peruana Unión, San Martín, Perú Author
  • Víctor Álvarez-Manrique Escuela Profesional de Enfermería, Facultad de Ciencias de la Salud, Universidad Peruana Unión, San Martín, Perú Author
  • Mardel Morales-García Universidad Peruana Unión, Lima, Perú Author
  • Liset Z. Sairitupa-Sanchez Universidad Peruana Unión, Lima, Perú Author
  • Wilter C. Morales-García Dirección General de Investigación, Universidad Peruana Unión, Lima, Perú Author

DOI:

https://doi.org/10.62486/agsalud2025183

Keywords:

Guillain-Barré Syndrome, associated factors, treatments

Abstract

Abstract
Objective: To conduct a brief literature review on Guillain-Barré Syndrome (GBS), its associated factors, and available treatments. Design: Literature review based on a narrative synthesis.
Databases: Scopus, ScienceDirect, SciELO, Google Scholar, and PubMed. Study Selection: Documents were selected through a critical literature review, considering inclusion and exclusion criteria. Results: The literature analysis included a corpus of 15 articles, comprising 2 statistical analyses, 6 narrative reviews, 3 systematic reviews, 2 observational studies, and 2 clinical cases. The studies primarily involved a population of adult men and women, children, and pregnant women, mostly from low-income and vulnerable backgrounds. Patients diagnosed with GBS were associated with COVID-19, Systemic Lupus Erythematosus (SLE), Posterior Reversible Encephalopathy Syndrome (PRES), Zika virus, and dengue. Conclusions: Research related to GBS highlights numerous causes and complications. GBS is significantly associated with muscle weakness, reduced mobility, and conditions such as SLE and PRES. During the COVID-19 pandemic, a slight increase in GBS cases was recorded. Although uncommon, GBS complications can lead to cardiovascular, respiratory, and gastrointestinal issues. Research does not explore in-depth preventive strategies or early management of these complications. There are currently limited treatments available to improve patient outcomes.

References

Althagafi, Z., Al-Bishi, S., Ansari, R., Alsolami, H., & Abdelkader, L. (2023). A Rare Case of Systemic Lupus Erythematosus With Diffuse Alveolar Hemorrhage and Guillain-Barre Syndrome. Cureus. https://doi.org/10.7759/cureus.33984

Belgrado, E., Del Negro, I., Bagatto, D., Lorenzut, S., Merlino, G., Gigli, G., & Valente, M. (2022).

Posterior Reversible Encephalopathy Syndrome in Guillain-Barré Syndrome: Just a

Problem of Immunoglobulins? Controversy From Two Atypical Case Reports. Frontiers in Neurology, 13. https://doi.org/10.3389/fneur.2022.817295

Bellanti, R., & Rinaldi, S. (2024). Guillain-Barré syndrome: a comprehensive review. European Journal of Neurology, 31(8). https://doi.org/10.1111/ene.16365

Bhoi, S., Jha, M., & Jaiswal, B. (2023). Guillain–Barre syndrome as the initial presentation of systemic lupus erythematosus: Case report with a systematic and literature review.

Medical Journal Armed Forces India, 79, S360–S364. https://doi.org/10.1016/j.mjafi.2023.02.007

Breville, G., Lascano, A. M., Roux-Lombard, P., Vuilleumier, N., & Lalive, P. H. (2021). Interleukin 8, a Biomarker to Differentiate Guillain-Barré Syndrome from CIDP. Neurology: Neuroimmunology and NeuroInflammation, 8(5).

https://doi.org/10.1212/NXI.0000000000001031

Brooks, J., Mix, F., Buck, J., & Walters, R. (2021). COVID-19-Induced Guillain-Barré Syndrome.

Cureus. https://doi.org/10.7759/cureus.19809

Censi, S., Bisaccia, G., Gallina, S., Tomassini, V., & Uncini, A. (2024). Guillain−Barré syndrome and SARS-CoV-2 infection: a systematic review and meta-analysis on a debated issue and evidence for the ‘Italian factor.’ European Journal of Neurology, 31(2).

https://doi.org/10.1111/ene.16094

Cheng-Yin, T., Shahrizaila, N., Hui-Ting, T., Khean-Jin, G., & Maw-Pin Tan. (2022). Cardiovascular Autonomic Assessment in Guillain-Barré Syndrome: A Longitudinal Study. Neurology India, 70(5), 1856–1859. https://doi.org/10.4103/0028-3886.359191

Cheyne, I., Gopinath, V. S., Muppa, N., Armas, A. E., Gil Agurto, M. S., Akula, S. A., Nagpal, S., Yousaf, M. S., & Haider, A. (2024). The Neurological Implications of COVID-19: A Comprehensive Narrative Review. Cureus. https://doi.org/10.7759/cureus.60376

Coviello, A., Iacovazzo, C., Vargas, M., Posillipo, C., Sagnelli, F., Diglio, P., Cirillo, D., & Servillo, G. (2024). A Death for Guillain-Barrè Syndrome After Receiving a COVID-19 Vaccine: A Case Report. Clinical Medicine Insights: Case Reports , 17.

https://doi.org/10.1177/11795476241274692

de Matos, L., Borges, A., Palmeira, A., Lima, V., Maciel, E., Fernandez, R., Mendes, J., & Romero,

G. (2022). Frequency of exposure to arboviruses and characterization of Guillain Barré syndrome in a clinical cohort of patients treated at a tertiary referral center in Brasília, Federal District. Revista Da Sociedade Brasileira de Medicina Tropical, 55.

https://doi.org/10.1590/0037-8682-0306-2021

Dominguez-Rojas, J., Atamari-Anahui, N., Caqui-Vilca, P., Tello-Pezo, M., & Muñoz-Huerta, P.

(2022). Posterior reversible encephalopathy syndrome in a child with severe multisystem inflammatory syndrome due to COVID-19. Revista Brasileira de Terapia Intensiva, 34(2), 295–299. https://doi.org/10.5935/0103-507X.20220028-en

Elendu, C., Osamuyi, E., Afolayan, I., Opara, N., Chinedu-Anunaso, N., Okoro, C., Nwankwo, A., Ezidiegwu, D., Anunaso, C., Ogbu, C., Aghahowa, S., Atuchukwu, C., Akpa, E., & Peterson,

J. (2024). Clinical presentation and symptomatology of Guillain-Barré syndrome: A

literature review. Medicine (United States), 103(30), e38890. https://doi.org/10.1097/MD.0000000000038890

Expósito, J., Carrera, L., Natera, D., Nolasco, G., Nascimento, A., & Ortez, C. (2022). SÍNDROME DE GUILLAIN-BARRÉ Y OTRAS NEUROPATÍAS AUTOINMUNES: TRATAMIENTO ACTUAL. 82, 82–88.

Felipe, L., Lima, A., Costa, K., Silva, N. da, Joaquim, D., de Sousa, D., & de Melo, A. (2021).

COMPREENSÃO DAS MANIFESTAÇÕES NEUROLÓGICAS INDUZIDAS POR INFECÇÕES PELO

NOVO CORONAVÍRUS: UMA REVISÃO INTEGRATIVA. Revista Enfermagem Atual In Derme,

95(36). https://doi.org/10.31011/reaid-2021-v.95-n.36-art.1108

Finsterer, J. (2022). Triggers of Guillain–Barré Syndrome: Campylobacter jejuni Predominates.

International Journal of Molecular Sciences, 23(22). https://doi.org/10.3390/ijms232214222

Gao, Z., Li, X., Peng, T., Hu, Z., Liu, J., Zhen, J., & Gao, Y. (2018). Systemic lupus erythematosus with Guillian-Barre syndrome: A case report and literature review. Medicine (United States), 97(25). https://doi.org/10.1097/MD.0000000000011160

Heidarpour, M., Sereshti, N., Shafie, D., Iraj, B., & Rezvanian, H. (2021). Cardiogenic Shock and Guillain-Barré Syndrome as the First Manifestations of Pheochromocytoma. Case Reports in Endocrinology, 2021. https://doi.org/10.1155/2021/6691095

López, V., Hernán, V., Yubero, R., & Céspedes, L. (2014). Acute respiratory insufficiency in the Guillain-Barré Syndrome. Revista Virtual de La Sociedad Paraguaya de Medicina Interna, 2(1), 42–53. https://doi.org/10.18004/rvspmi/2014.01(02)42-053

Ian, D., & Zachary, P. (2021). Fall in people post-Guillain-Barrré syndrome in the United Kingdom: A national cross-sectional survey of comunity based adults. Health and Social Care in the Commynity.

Keh, R., Scanlon, S., Datta-Nemdharry, P., Donegan, K., Cavanagh, S., Foster, M., Skelland, D., Palmer, J., Machado, P., Keddie, S., Carr, A., & Lunn, M. (2023). COVID-19 vaccination and Guillain-Barr syndrome: analyses using the National Immunoglobulin Database. Brain, 146(2), 739–748. https://doi.org/10.1093/brain/awac067

Khatib, H. El, Naous, A., Ghanem, S., Dbaibo, G., & Rajab, M. (2018). Case report: Guillain-Barre syndrome with pneumococcus – A new association in pediatrics. IDCases, 11, 36–38.

https://doi.org/10.1016/j.idcr.2017.11.009

Kuriyama, K., Koyama, Y., Tsuto, K., Tokuhira, N., Nagata, H., Muramatsu, A., Oshiro, M.,

Hirakawa, Y., Iwai, T., & Uchiyama, H. (2020). Gastric lymphoma complicated by

phlegmonous gastritis and Guillain-Barré syndrome: A case report. Medicine (United States), 99(18), E20030. https://doi.org/10.1097/MD.0000000000020030

Kuroiwa, R., Tateishi, Y., Oshima, T., Shibuya, K., Inagaki, T., Murata, A., & Kuwabara, S. (2023). Cardiovascular autonomic dysfunction induced by mechanical insufflation-exsufflation in Guillain–Barré syndrome. Respirology Case Reports, 11(5).

https://doi.org/10.1002/rcr2.1135

Leonhard, S., Mandarakas, M., De, F., Aquino Gondim, Bateman, K., Ferreira, M., Cornblath, D., Van Doorn, P., Dourado, M., Hughes, R., Islam, B., Kusunoki, S., Pardo, C., Reisin, R., Sejvar, J., Shahrizaila, N., Soares, C., Umapathi, T., Wang, Y., … Jacobs, B. (2021). ARTÍCULO

ESPECIAL-REVISIÓN. 81, 817–836.

Li, Y., Zhao, R., Li, L., Xue, H., Meng, H., Li, G., Liang, F., Zhang, H., Ma, J., Pang, X., Wang, J., Chang, X., Guo, J., & Zhang, W. (2024). Relative frequencies and clinical features of

Guillain-Barré Syndrome before and during the COVID-19 pandemic in North China. BMC Infectious Diseases, 24(1). https://doi.org/10.1186/s12879-024-09401-1

López-Hernández, J., Vargas-Cañas, E., Estrada, A., & Galnares-Olalde, J. (2023). Guillain-Barre syndrome before and during the COVID-19 pandemic in a referral center of Mexico.

Gaceta Médica de México, 159(4). https://doi.org/10.24875/gmm.m23000787 Lunn, M. P., Cornblath, D. R., Jacobs, B. C., Querol, L., Van Doorn, P. A., Hughes, R. A., &

Willison, H. J. (2021). Epidemiological and cohort study finds no association betwen COVID-19 and Guillain-Barré syndrome. In Brain (Vol. 144, Issue 2, pp. 368–371). Oxford University Press. https://doi.org/10.1093/brain/awaa444

Mehdizadeh, C., Moukus, A., Bannoud, M., Smith, M., & Ansari, S. (2023). Guillain-Barré Syndrome Presenting as Symmetrical Proximal Muscle Weakness: An Atypical Presentation. Cureus. https://doi.org/10.7759/cureus.50259

Nanda, S. K., Jayalakshmi, S., Ruikar, D., & Surath, M. (2013). Twelfth cranial nerve involvement in Guillian Barre syndrome. Journal of Neurosciences in Rural Practice, 4(3), 338–340.

https://doi.org/10.4103/0976-3147.118804

Oguri, T., Sasada, S., Shimizu, S., Shigematsu, R., Tsuchiya, Y., Ishioka, K., Takahashi, S., Oki, K., Kimura, Y., Seki, R., Hirose, S., & Nakamura, M. (2021). A Case of Guillain-Barré Syndrome and Stevens-Johnson Syndrome/Toxic Epidermal Necrosis Overlap After Pembrolizumab Treatment. Journal of Investigative Medicine High Impact Case Reports, 9.

https://doi.org/10.1177/23247096211037462

Oliveira, R. B. de, Queiroz, P. F. dos S., Panini, V. de O., Silva, I. M. C. P. da, & Lima, A. B. L. (2024). Relação entre COVID-19 e Síndrome de Guillain-Barré em adultos: revisão sistemática. Journal Archives of Health, 5(3), e1701.

https://doi.org/10.46919/archv5n3espec-029

Ousseiran, Z., Fares, Y., & Chamoun, W. (2023). Neurological manifestations of COVID-19: a systematic review and detailed comprehension. International Journal of Neuroscience, 133(7), 754–769. https://doi.org/10.1080/00207454.2021.1973000

Pérez, R. (2018). Tratamiento en fase aguda y de recuperación en el Síndrome de Guillain – Barré. Revisión bibliográfica.

Phillips O. (2019). Actualización en el Síndrome de Guillain-Barré. Revista Medica Sinergia, 4(11), 290. https://doi.org/10.31434/rms.v4i11.290

Puga, M., Sanchez, A., & Bravo, R. (2003). SÍNDROME DE GUILLAIN BARRÉ. Revista Cubana de Medicina Militar, 32(2), 42–137.

Santos, M., De Brito, B., Da Silva, F., Sampaio, M., Marques, H., E Silva, N., De Magalhães, D., & De Melo, F. (2020). Helicobacter pylori infection: Beyond gastric manifestations. World Journal of Gastroenterology, 26(28), 4076–4093.

https://doi.org/10.3748/wjg.v26.i28.4076

Páez-Macías, S., Bucay, J., Guanga, S., Huaraca, A., & Pilozo, D. (2022). Síndrome de Guillain-

Barré como forma de presentación de lupus eritematosos sistémico en paciente

masculino. Revista Cubana de Reumatología, 24(2). https://orcid.org/0000-0002-2951- 4000

Surve, R., Sharma, K., Sharma, P., Nisal, R., Pendharkar, Hima., & Kulkarni, G. (2024). PRESenting a Challenge: Posterior Reversible Encephalopathy Syndrome in Pediatric Patients With

Guillain-Barré Syndrome: A Case Series and Review of Literature. Pediatric Neurology, 156, 162–169. https://doi.org/10.1016/j.pediatrneurol.2024.04.018

Tellería-Díaz, A., & Calzada-Sierra, D. (2002). Síndrome de Guillain-Barré. Revista de Neurología, 34, 954–966.

Tetteh-Wayoe, E., Duodu, F., Pekyi-Boateng, P. K., Agyeman Badu, N. B., Akpalu, A., & Adjei, P.

(2023). Guillain-Barre syndrome and pulmonary embolism in an adult female with COVID-19 infection in Ghana: A case report. Medicine (United States), 102(20), E33754. https://doi.org/10.1097/MD.0000000000033754

Thomma, R. C. M., Fokke, C., Walgaard, C., Vermeulen-de Jongh, D. M. C., Tio-Gillen, A., Rijs, W., Doorn, P., Huizinga, R., & Jacobs, B. (2023). High and Persistent Anti-GM1 Antibody Titers Are Associated With Poor Clinical Recovery in Guillain-Barré Syndrome.

Neurology(R) Neuroimmunology & Neuroinflammation, 10(4). https://doi.org/10.1212/NXI.0000000000200107

Top, K. A., Shulha, H., Muller, M., Valiquette, L., Vanderkooi, O., Kellner, J., Sadarangani, M.,

Irvine, M., McGeer, A., Isenor, J. E., Marty, K., Soe, P., De Serres, G., & Bettinger, J. (2024). Participant-reported neurological events following immunization in the Canadian National Vaccine Safety Network-COVID-19 vaccine (CANVAS-COVID) study. Vaccine, 42(26).

https://doi.org/10.1016/j.vaccine.2024.126445

Wang, Y., Sun, S., Zhu, J., Cui, L., & Zhang, H. L. (2015). Biomarkers of Guillain-Barré Syndrome: Some Recent Progress, More Still to Be Explored. In Mediators of Inflammation (Vol.

2015). Hindawi Publishing Corporation. https://doi.org/10.1155/2015/564098

Xiromerisiou, G., Kalampokini, S., Rikos, D., Provatas, A., Tsouris, Z., Markou, K., Ralli, S., & Dardiotis, E. (2020). Posterior reversible encephalopathy in a GT1a positive

oculopharyngeal variant of Guillain-Barré syndrome: A case-report and review of the literature. In Clinical Neurology and Neurosurgery (Vol. 196). Elsevier B.V.

https://doi.org/10.1016/j.clineuro.2020.106037

Yevgi, R. (2022). Relationship Between Acute Phase Reactants and Disability in Guillian-Barré Syndrome During the COVID-19 Pandemic. Archives of Medical Research, 53(2), 179–185. https://doi.org/10.1016/j.arcmed.2021.10.002

Zhu, C., Wang, H., Zhang, Y., Wang, W., Wang, J., & Li, W. (2024). Experience of treatment in

critical Guillain-Barre Syndrome case after COVID-19 vaccination. International Journal of Developmental Neuroscience, 84(4), 342–348. https://doi.org/10.1002/jdn.10325

Zöllei Eva, Avramov, K., Gingl, Z., & Rudas, L. (2000). Severe cardiovascular autonomic dysfunction in a patient with Guillain-Barre syndrome: a case report. Autonomic Neuroscience: Basic and Clinical, 86, 94–98. www.elsevier.com/locate/autneu.

Downloads

Published

2025-02-18

Issue

Section

Review

How to Cite

1.
López-Peña E, Camizán-Julca D, Dávila-Pezo J, Morales-Ruiz S, Álvarez-Manrique V, Morales-García M, et al. Factors associated, symptoms, and treatments of guillain-barré syndrome: a narrative review. AG Salud [Internet]. 2025 Feb. 18 [cited 2025 Apr. 9];3:183. Available from: https://agsalud.ageditor.org/index.php/agsalud/article/view/183